登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式(希尔记法):
C16H18FN3O2
化学文摘社编号:
分子量:
303.33
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
8072099
grade
analytical standard
Quality Level
assay
≥98.0% (HPLC)
shelf life
limited shelf life, expiry date on the label
drug control
USDEA Schedule IV
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
impurities
≤1.0% water (calc. from elemental analysis)
application(s)
forensics and toxicology
veterinary
format
neat
storage temp.
2-8°C
SMILES string
FC1=CC=C(CNC2=CC(N)=C(NC(OCC)=O)C=C2)C=C1
InChI
1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21)
InChI key
PCOBBVZJEWWZFR-UHFFFAOYSA-N
Gene Information
human ... KCNQ1(3784), KCNQ2(3785), KCNQ3(3786), KCNQ4(9132), KCNQ5(56479)
General description
瑞替加滨是一种抗癫痫药物,它通过诱导稳态激活的大型超极化转变(hyperpolarizing shift)来激活神经元 KCNQ 型 K+ 通道。
Application
瑞替加滨可用作参考标准品,用于通过高效液相色谱结合串联质谱和正离子大气压化学电离(HPLC-APCI-MS/MS)测定生物基质中的瑞替加滨。
Biochem/physiol Actions
瑞替加滨是一种 Kv7.2-7.5 钾通道激活剂; 抗惊厥药。
瑞替加滨(依佐加滨)是一种具有抗惊厥活性的 Kv7.2-7.5 (KCNQ2-5)神经元钾通道开放剂。
Still not finding the right product?
Explore all of our products under 瑞替加滨
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Determination of retigabine and its acetyl metabolite in biological matrices by on-line solid-phase extraction (column switching) liquid chromatography with tandem mass spectrometry.
Knebel GN, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications, 748(1), 97-111 (2000)
Identification, characterization, synthesis and HPLC quantification of new process-related impurities and degradation products in retigabine.
Dousa M, et al.
Journal of Pharmaceutical and Biomedical Analysis, 94, 71-76 (2014)
Lyubov I Brueggemann et al.
Molecular pharmacology, 86(3), 330-341 (2014-06-20)
Recent research suggests that smooth muscle cells express Kv7.4 and Kv7.5 voltage-activated potassium channels, which contribute to maintenance of their resting membrane voltage. New pharmacologic activators of Kv7 channels, ML213 (N-mesitybicyclo[2.2.1]heptane-2-carboxamide) and ICA-069673 N-(6-chloropyridin-3-yl)-3,4-difluorobenzamide), have been reported to discriminate among
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 90221-25MG | 04061833246481 |

